These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7010994)

  • 21. Combined treatment with minoxidil and captopril in refractory hypertension.
    Traub YM; Levey BA
    Arch Intern Med; 1983 Jun; 143(6):1142-4. PubMed ID: 6344825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The hypotensive effect of propranolol in captopril-treated patients does not involve the plasma renin--angiotensin--aldosterone system.
    Staessen J; Fagard R; Lijnen P; Verschueren LJ; Amery A
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():441s-444s. PubMed ID: 7032826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Captopril combined with thiazide lowers renin substrate concentration: implications for methodology in renin assays.
    Rasmussen S; Damkjaer Nielsen M; Giese J
    Clin Sci (Lond); 1981 May; 60(5):591-3. PubMed ID: 7018804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Captopril in the treatment of hypertension (author's transl)].
    Favre L
    Schweiz Rundsch Med Prax; 1981 Aug; 70(35):1487-90. PubMed ID: 7024978
    [No Abstract]   [Full Text] [Related]  

  • 25. Prediction of hyperkalemia associated with prolonged treatment with captopril by glucose-induced acute serum potassium changes.
    Radó JP
    Exp Clin Endocrinol; 1984 Oct; 84(2):143-7. PubMed ID: 6396097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine.
    MacGregor GA; Markandu ND; Smith SJ; Sagnella GA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S82-7. PubMed ID: 2580182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minoxidil in refractory hypertension.
    Makker SP
    J Pediatr; 1975 Apr; 86(4):621-3. PubMed ID: 1092824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deterioration of renal function and hyperkalemia in hypertensive patients with impaired renal function during captopril administration.
    Kodama K; Morotomi Y; Kida O; Higa T; Someya N; Kondo K; Tanaka K
    Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):327-35. PubMed ID: 3894730
    [No Abstract]   [Full Text] [Related]  

  • 29. Rise in plasma concentration of aldosterone during long-term angiotensin II suppression.
    Staessen J; Lijnen P; Fagard R; Verschueren LJ; Amery A
    J Endocrinol; 1981 Dec; 91(3):457-65. PubMed ID: 7035596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined therapy with captopril and potassium supplementation. A potential for hyperkalemia.
    Burnakis TG; Mioduch HJ
    Arch Intern Med; 1984 Dec; 144(12):2371-2. PubMed ID: 6391404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Captopril and minoxidil for malignant hypertension in an infant.
    Zenk KE; Uchiyama N; Petty B; Morgan BC
    Clin Pharm; 1984; 3(3):311-3. PubMed ID: 6375942
    [No Abstract]   [Full Text] [Related]  

  • 32. Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril.
    Textor SC; Bravo EL; Fouad FM; Tarazi RC
    Am J Med; 1982 Nov; 73(5):719-25. PubMed ID: 6291388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
    Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Captopril in the treatment of hypertension.
    Staessen J; Fagard R; Lijnen P; Amery A
    Acta Clin Belg; 1982; 37(3):164-84. PubMed ID: 6214916
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term captopril treatment in moderate to severe hypertension.
    Santucci A; Aguglia F; De Mattia G; Ficara C; Balsano F
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):77S-79S. PubMed ID: 6753908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose-induced hyperkalemia developing in the upright position in captopril-treated hypertensives.
    Radó JP; Bános C; Gercsák G; Molnár Z; Pató E; Csabuda M
    Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):161-4. PubMed ID: 6755590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
    Weber MA; Drayer JI; Priest RT; Chen TC
    Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of captopril with propranolol in the treatment of mild and moderate essential hypertension.
    Seedat YK
    S Afr Med J; 1979 Dec; 56(23):983-6. PubMed ID: 399093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes of the intralymphocytic sodium concentration after acute and chronic captopril administration.
    Santucci A; Aguglia F; Violi F; De Mattia G
    Am J Cardiol; 1982 Apr; 49(6):1513-4. PubMed ID: 7041589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertension.
    Aldigier JC; Plouin PF; Guyene TT; Thibonnier M; Corvol P; Menard J
    Am J Cardiol; 1982 Apr; 49(6):1447-52. PubMed ID: 7041584
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.